Response to Hepatitis B Vaccine in HBsAg/Anti-HBs Negative and Anti-HBc Positive Subjects

By Sünbül Mustafa   Leblebicioglu Hakan   Esen Saban   Eroglu Cafer   Barut Sener  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 3, 2000-10 ,pp. : 315-316

Informa Healthcare

Access to resources Recommend Favorite

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

By Davis H.L.   Millan C.L.B.   Mancini M.   McCluskie M.J.   Hadchouel M.   Comanita L.   Tiollais P.   Whalen R.G.   Michel M.-L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 849-852

Elsevier

Access to resources Recommend Favorite

Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E263-E274

John Wiley & Sons Inc

Access to resources Recommend Favorite

False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines

By Otag F.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3734-3737

Elsevier

Access to resources Recommend Favorite

HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report

By Dong Pei-ling   Zhang Xin   Zhao Wen-min   Ding Hui-guo  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 6, 2013-12 ,pp. : 1188-1192

Springer Publishing Company

Access to resources Recommend Favorite